| 1a | Elect Director Michael L. Eskew | Oppose |
| 1b | Elect Director William G. Kaelin, Jr. | For |
| 1c | Elect Director David A. Ricks | Oppose |
| 1d | Elect Director Marschall S. Runge | For |
| 1e | Elect Director Karen Walker | For |
| 2 | Advisory Vote on Executive Compensation | Abstain |
| 3 | Appoint the Auditors | Oppose |
| 4 | Board Proposal to Declassify the Board/introduce Annual Director Elections | For |
| 5 | Board Proposal to Eliminate Supermajority Voting | For |
| 6 | Shareholder Resolution: Lobbying Expenditures Disclosure | For |
| 7 | Shareholder Resolution: Animal Testing/Rights | For |
| 8 | Shareholder Resolution: Introduce an Independent Chairman Rule | For |
| 9 | Proponent seeks ideological diversity to make sure that right-wing views are represented | Oppose |
| 10 | Shareholder Resolution: Integrating Drug Price Risks into Performance Metrics for Executive Remuneration | For |
| 11 | Shareholder Resolution: Deferral of Annual Cash Bonuses | For |
| 12 | Shareholder Resolution: Disclosure of Clawbacks | For |
